Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2017

2017-03-15
Price :
Published : Mar-2017
No. of Pages : 49
order by fax Inquire before Buying request discount
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Hormonal Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profile Snapshots 26
Appendix 46
Abbreviations 46
Definitions 46
Research Methodology 47
Secondary Research 48
About GlobalData 48
Contact Us 48
Disclaimer 49
Source 49

List of Tables
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region, 2017* 6
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Hormonal Disorders Clinical Trials, G7 Countries (%), 2017* 14
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase, 2017* 17
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 18
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 22
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25

List of Figures
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Hormonal Disorders Clinical Trials, G7 Countries (%), 2017* 13
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 17
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 18
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 22
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25
GlobalData Methodology 47
Filed in: Pharmaceutical
Publisher : GlobalData